Aldeyra Therapeutics: Executives
Todd C. Brady, M.D., Ph.D.President and Chief Executive OfficerFY2023
Stephen G. Machatha, Ph.D.Chief Development OfficerFY2025
Michael AlfieriPrincipal Financial Officer and Principal Accounting OfficerFY2024
3 executives

Named executives and their total pay come from the Summary Compensation Table of the latest proxy statement.